Navigation Links
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Date:5/20/2013

style-type:disc" type="disc">
  • A more than 30 percent albuminuria reduction was observed in 51 and 55 percent of the atrasentan subjects, respectively (P=0.001).ii
  • Changes in estimated glomerular filtration rate (eGFR), another important measure of kidney function, were measured  compared to placebo in both groups (0.75mg= -0.81/min/1.73m2; p=0.412 and 1.25mg= -0.91 ml/min/1.73m2; p=0.355), and did not change significantly compared to placebo.ii
  • In the Phase 2b studies, the observed adverse events were similar among the three treatment and placebo groups.  The most commonly observed adverse events included peripheral edema (35 percent in 0.75mg arm, 42 percent in 1.25 mg arm vs. 42 percent on placebo), diarrhea and constipation (13 percent in 0.75mg arm, 21 percent in 1.25 mg arm vs. 14 percent on placebo).  There were no significant differences in the rate of peripheral edema or diarrhea and constipation among the treatment and placebo arms.ii 

    A small percentage of subjects discontinued the study due to adverse events (8 percent on 0.75 mg, 15 percent on 1.25mg vs. 0 on placebo), with edema as the most commonly cited reason.ii

    Importantly, the study concluded that the 0.75 mg dose of atrasentan administered orally once daily showed the best efficacy-safety balance, informing the dosing of atrasentan selected for further investigation in the Phase 3 clinical study.ii

    About SONAR Study

    SONAR is a randomized, double-blind, parallel, placebo-controlled, multicenter study designed to assess the effects of atrasentan (0.75 mg administered orally once a day) on renal outcomes in patients with type 2 diabetic nephropathy (diabetic kidney disease) while they continue to be treated with the current standard of care: the maximum tolerated labeled daily dose of a RAS inhibitor, such as an ACE inhibitor or an ARB, and a diuret
    '/>"/>

    SOURCE AbbVie
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. AbbVie Named to S&P 500 Dividend Aristocrat Index
    2. AbbVie Issues Inaugural Full-Year Outlook for 2013
    3. AbbVie to Present at Barclays Global Health Care Conference
    4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
    5. AbbVie to Host First-Quarter Earnings Conference Call
    6. AbbVie Reports First-Quarter 2013 Financial Results
    7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
    8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
    9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
    10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
    11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
    (Date:9/17/2014)... Sept. 17, 2014  Dr. Stephen Loyd , ... House today for National Recovery Month, stars in a ... released today. Consumer advocates were also joined by a ... out after losing her fiancée because of a preventable ... had a history of crack cocaine abuse. Proposition 46 ...
    (Date:9/17/2014)... , Sept. 17, 2014  Decision Resources ... (CD/UC) patients eligible for biologic therapy, only ... biologic. Surveyed gastroenterologists cite patients, discomfort with ... low penetration rates, followed by cost-related issues ... patients receiving biologics, Janssen Biotech,s Remicade and ...
    Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
    (Date:9/17/2014)... Battle Creek, MI (PRWEB) September 17, 2014 ... Recovery , an open-ended drug and alcohol treatment program ... gives them a solid foundation in recovery they can ... and depression. , “About 20% of Americans who are ... or both,” commented A Forever Recovery’s CEO Per ...
    (Date:9/17/2014)... has been reserved for the very healthy. Astronauts ... highest physical and psychological standards to prepare them ... of commercial spaceflight, average people can now fly ... very little information about what medical conditions or ... spaceflight environment, as most medical conditions have never ...
    (Date:9/17/2014)... In its latest blog post, Best ... having family close by during a stay in rehab can ... is successful, is highlighting a member of the therapeutic care ... of addicts across the country and around the world: dogs. ... the blood pressure, heart rate, and stress levels in recovering ...
    (Date:9/17/2014)... 2014 North Central Surgical Center is ... awards for their top-notch services. The hospital was the ... and GYN surgery. , Hospital-wide, North Central was the ... have received this award for two years in a ... percent in the nation for Patient Safety in 2014 ...
    (Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- A blood ... could provide doctors with a better assessment of the ... If used routinely, this blood test could ... working and actually begins promoting tumor growth, the researchers ... given to patients with advanced prostate cancer and often ...
    Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3Health News:Space: The final frontier… open to the public 2Health News:Latest Best Drug Rehabilitation Blog Post Highlights How Dogs are Helping Addicts Recover 2Health News:North Central Surgical Center Receives Several Accolades 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2
    ... Romania. But now new cases of deaths of birds have been ... in all directions from the Danube Delta. This delta is a ... all the birds that come to Europe. ... infected with bird flu. ,Bird flu is caused by ...
    ... loss of lung functions may be prevented by Vitamin ... lungs stand to benefit from greater concentrations of the ... breakfast cereals, dairy products and fatty fish. Exposure to ... vitamin D. ,The University of Auckland’s researchers ...
    ... depot fire accident has been described as an environmental tragedy ... flames are reportedly spewing out a toxic cocktail of chemicals.// ... fuel tank led to the suspension of the firefighting efforts. ... signal had been given. ,As many as 150 ...
    ... of patients who suffer from Parkinson disease as a ... to a study conducted by the University of Alabama.// ... the levodopa medication for bringing the symptoms under control. ... levodopa medication may result in dyskinesias and motor fluctuations ...
    ... Scotland figures have revealed that about 34% of the ... or overweight. The Information Statistics Division (ISD) has published ... directly connected to latter year // problems like ... disease, which may prove to be an expensive proposition ...
    ... increase in demand for Palliative care for treatment of ... Hospitals, which has been reported in the Journal of ... chemotherapy or other treatments no more works, it is ... their suffering. It is found that there is a ...
    Cached Medicine News:Health News:Study Says Vitamin D Is Good For Lungs 2Health News:Firefighters Continue To Battle Blaze 2
    Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
    Features a built-in throat illuminator, providing 30% more magnification and twice the field of view. Adjustable focus....
    ... The Novus Spectra photocoagulator delivers ... in diode-pumped solid-state (DPSS) technology. Diode ... power from the compact Novus Spectra ... ensures stable beam output and system ...
    A standard, durable and reliable indirect....
    Medicine Products: